Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adjuvant Tamoxifen
36%
Adjuvant Therapy
36%
Age at Diagnosis
12%
Androgen-producing Tumors
36%
Biological Characteristics
9%
Biological Response Modifiers
12%
Breast Cancer
36%
Carcinogenicity
36%
Carcinoma Cell Line
36%
Cardiac Magnetic Resonance Imaging (cMRI)
12%
CD4 Positive Cells
12%
Cell-mediated Immune Response
12%
Cellular Expression
12%
Clinicopathologic Study
36%
Cystic Teratoma
36%
Decompression
12%
Dermoid Cyst
18%
Disorder Severity
12%
During Pregnancy
36%
Early Embryo
18%
Ectopic Ovary
72%
Electrothermal Bipolar Vessel Sealer
21%
Endometrial Cancer
72%
Endometrial Cancer Patients
12%
Endometrial Carcinoma
36%
Endometrioid
18%
Endometrioid Adenocarcinoma
16%
Endometrioid Carcinoma
9%
Endometrium
36%
Epithelial Origin
18%
Estrogen
21%
Extremely Rare
12%
Fallopian Tube
36%
Fimbriae
18%
Gestational Age
12%
Gonadal Ridge
18%
Hemodynamic Changes
12%
Histological Subtypes
18%
HLA-DR
36%
HMLH1
18%
HMSH2
18%
Human Leukocyte Antigen
36%
Hyperplasia
18%
Immunohistochemical Examination
12%
Immunohistochemical Study
36%
Immunological Therapy
18%
Infiltration
12%
Inherent Error
18%
Intratumoral Injection
12%
KRAS mutation
18%
L-cells
14%
Laparoscopy
18%
Left Ovary
18%
Ligature
21%
Loop Type
21%
Lower Limb
12%
Lymph Node Metastasis
18%
Lymphocyte Infiltration
36%
Mesenchyme
18%
Microsatellite Instability-high (MSI-H)
18%
Microvascular Invasion
18%
Model Comparison
36%
Monoclonal Antibody
12%
Monopolar Electrocautery
21%
Neurological Sequelae
12%
No Significant Difference
24%
Normal Position
18%
Older Patients
14%
Older Women
12%
Past Users
36%
Poor Prognosis
14%
Porcine Model
36%
Postoperative Adhesions
36%
Pregnancy Disorders
12%
Progressive Paralysis
12%
Resection
36%
Right Ovary
18%
Sizofiran
36%
Spinal Epidural Hematoma
36%
Stapling Device
21%
Steroid Hormones
36%
Structural Change
12%
Tamoxifen Therapy
19%
TP53 mutation
18%
Tumor
50%
Tumor Cells
12%
Tumor Regression
12%
Tumor Tissue
12%
Ultrasonically Activated Scalpel
21%
Undifferentiated Carcinoma
36%
Upper Limb
12%
Uterine Cancer
36%
Uterine Horn
36%
Vaginal Cancer
36%
Vascular Hemodynamics
12%
Vascular Wall
12%
Wolffian Duct
18%
Women of Reproductive Age
25%
Worse Prognosis
15%
Young Patients
14%
Medicine and Dentistry
Adenocarcinoma
18%
Adrenal Gland
9%
Alpha Catenin
7%
Anaplastic Carcinoma
36%
Androgen
36%
Androstenedione
9%
Arteriovenous Malformation
12%
Blood Flow
36%
Breast Cancer
45%
Cancer
37%
Carcinogenesis
9%
Carcinogenicity
36%
Carcinoma Cell Line
36%
Cell Contact
7%
Cell Line
21%
Clear Cell
9%
Clinical Feature
36%
Dentigerous Cyst
36%
Depo-Provera
9%
Diseases
12%
Doppler Flowmetry
24%
Doppler Ultrasound
36%
Dysmenorrhea
12%
Endometrial Biopsy
9%
Endometrioid Carcinoma
9%
Endometrium
36%
Endometrium Carcinoma
36%
Estrogen
41%
Fallopian Tube
36%
fertility
9%
Fimbria
18%
Fulguration
21%
Gestagen
9%
Gestational Age
12%
Gray Scale Echography
12%
Hemodynamic
12%
Hirsutism
18%
Histology
14%
Hyperandrogenism
18%
Hyperplasia
18%
Immunohistochemistry
9%
In Vitro
7%
In Vitro Fertilisation
9%
Laboratory Test
9%
Laparoscopic Surgery
61%
Leydig Cell Tumour
9%
Lower Limb
12%
Lymph Node Metastasis
25%
Lymphangioleiomyomatosis
36%
Magnetic Resonance Angiography
24%
Magnetic Resonance Imaging
45%
Medroxyprogesterone Acetate
9%
Mesenchyme
18%
Microsatellite Instability
18%
Morphology
29%
Neoplasm
45%
Oral
9%
Ovarian Tumor
18%
Ovarian Vein
18%
Ovariectomy
9%
Ovulation Induction
14%
Paralysis
12%
Pathogenesis
12%
Pelvis
28%
Peritonitis
36%
Postmenopause
12%
Prasterone Sulfate
9%
Primary Ovarian Insufficiency
36%
Primary Tumor
7%
Primordial Follicle
36%
Progesterone
14%
Progesterone Derivative
9%
Protein Expression
9%
Protein P53
27%
Pulse Rate
12%
Ras Signaling
18%
SCID Mouse
7%
Scintigraphy
9%
Secondary Amenorrhea
9%
Sequela
12%
Spin Echo
12%
Spinal Hematoma
36%
Steroid Hormone
36%
Tamoxifen
100%
Testosterone
9%
Tissue Adhesion
36%
Treatment Effect
9%
Tuberous Sclerosis
21%
Tumor
48%
Upper Limb
12%
Uterine Artery
12%
Uterine Cancer
72%
Uterus Horn
36%
Uvomorulin
7%
Vaginal Ultrasonography
12%
Vascular Disease
12%
Vein Catheterization
36%
Virilization
9%
Wolffian Duct
18%
X-Ray Computed Tomography
9%